MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 Pennsylvania Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Pennsylvania cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 Pennsylvania Part D plan
DrugHumana Basic Rx Plan$6.60/moS5884-104Wellcare Value Script$8.20/moS4802-141Wellcare Classic$14.70/moS4802-080Humana Value Rx Plan$19.40/moS5884-185SilverScript Choice$22.70/moS5601-012AARP Medicare Rx Saver from UHC$43.50/moS5921-351HealthSpring Extra Rx$62.60/moS5617-356HealthSpring Assurance Rx$74.00/moS5617-215AARP Medicare Rx Preferred from UHC$121.90/moS5921-388Humana Premier Rx Plan$123.60/moS5884-152Blue Rx PDP Complete$164.80/moS5593-003Blue Rx PDP Plus$193.20/moS5593-002
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 31/31dTier 525%QL 31/31d
Dovatodolutegravir and lamivudineTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 31/31dTier 525%QL 31/31d
Triumeqabacavir/dolutegravir/lamivudineTier 433%QL 180/30dTier 440%Tier 428%Tier 433%QL 180/30dTier 435%Tier 441%QL 180/30dTier 431%QL 300/30dTier 431%QL 300/30dTier 433%QL 180/30dTier 450%QL 180/30dTier 525%Tier 525%
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%Tier 525%
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 31/31dTier 525%QL 31/31d
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 31/31dTier 525%QL 31/31d
Julucadolutegravir and rilpivirineTier 525%QL 30/30dTier 525%Tier 525%Tier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 533%QL 30/30dTier 525%Tier 525%
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 31/31dTier 525%QL 31/31d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 433%QL 30/30dTier 440%QL 30/30dTier 428%QL 30/30dTier 433%QL 30/30dTier 435%QL 30/30dTier 441%QL 30/30dTier 431%QL 30/30dTier 431%QL 30/30dTier 433%QL 30/30dTier 450%QL 30/30dTier 425%Tier 425%
TivicaydolutegravirTier 525%QL 60/30dTier 525%Tier 525%Tier 526%QL 60/30dTier 525%Tier 525%QL 60/30dTier 431%QL 180/30dTier 431%QL 180/30dTier 531%QL 60/30dTier 533%QL 60/30dTier 525%Tier 525%

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.